EOLS FY 2020 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$353M

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$57M+61.9% YoY

Gross Profit

$38M67.6% margin

Operating Income

-$153M-270.7% margin

Net Income

-$163M-288.3% margin

EPS (Diluted)

$-4.83

Cash Flow

Operating Cash Flow

-$58M

Free Cash Flow

-$61M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$209M

Total Liabilities

$282M

Stockholders' Equity

-$73M

Cash & Equivalents

$103M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$35M	+61.9%
Gross Profit	$38M	$27M	+42.1%
Operating Income	-$153M	-$99M	-54.7%
Net Income	-$163M	-$90M	-81.1%